+44 79 19 49 39 39 wilsonblaney@gmail.com

First drug to slow Alzheimer’s Disease unveiled in landmark breakthrough
Although trials are continuing and will not end until next year, the treatment could be available for use by 2018 if approved by the Medicines & Healthcare products Regulatory Agency (MHRA) and The National Institute for Health and Care Excellece (NICE).
Read more on Telegraph.co.uk

 

UK patients offered app to report adverse reactions
The UK has moved its Yellow Card Scheme into the mobile age, launching a smartphone app that allows patients to report potential side-effects and adverse reactions directly to the MHRA. The medicines regulator’s free new app – which is also aimed at …
Read more on PMLiVE (blog)

 

UK’s MHRA helps ‘future-proof’ Fujifilm’s mammalian cell culture manufacturing
In a rare move for the UK’s MHRA (Medicines and Healthcare products Regulatory Agency), the regulator has helped to “future-proof” CMO Fujifilm Diosynth Biotechnologies’ mammalian cell culture manufacturing facility in Billingham, UK against potential …
Read more on BioPharma-Reporter.com

 

Share Button